Medical specialists from France tagged as investigators in clinical trials studying Inflammatory Myofibroblastic Tumor

Total 1 results

Veronique Minard, Prof Dr
Seen in:
- Paris, Institut Gustave Roussy
Trials:
- NCT04925609 (Principal Investigator)
Conditions:

Clinical Trials on Inflammatory Myofibroblastic Tumor

Jean M. Tersak, M.D.
Pfizer

No longer available

Treatment With Crizotinib Single Patient Expanded Access IND 134375

Inflammatory Myofibroblastic Tumour
Sun Yat-sen University

Unknown

Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor

Inflammatory Myofibroblatic Tumor

China
Federal Research Institute of Pediatric Hematology...

Unknown

Study of Crizotinib in Children and Adolescents With Myofibroblastic Tumors

Inflammatory Myofibroblastic Tumor

Russian Federation
Takeda

Withdrawn

Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid Tumors

Solid Tumors | Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumors
Princess Maxima Center for Pediatric Oncology
Takeda

Recruiting

Brigatinib in Pediatric and Young Adult Patients With ALK+ ALCL, IMT or Other Solid Tumors (Briga-PED)

Anaplastic Large Cell Lymphoma, ALK-Positive | Inflammatory Myofibroblastic Tumor | Other Solid Tumor

France, Netherlands
IHU Strasbourg

Completed

Assessment of Intraoperative Probe-based Confocal Laser Endomicroscopy in Digestive and Endocrine Surgery: a Pilot Study (Pilot pCLE)

Malignant Tumor | Inflammatory Disease | All Surgical Conditions Usually Necessitating Frozen Section | Benign Tumor

France
Novartis Pharmaceuticals

Terminated

Ceritinib Rare Indications Study in ALK+ Tumors

Glioblastoma | Anaplastic Large Cell Lymphoma | Inflammatory Myofibroblastic Tumor | Tumors With Aberrations in ALK

France, Czechia, Italy, Spain, Korea, Republic of, Thailand, Israel, Denmark
National Cancer Institute (NCI)

Active, not recruiting

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Leiomyosarcoma | Fibrosarcoma | Liposarcoma | Mesenchymal Chondrosarcoma | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Malignant Peripheral Nerve Sheath Tumor | PEComa | Synovial Sarcoma | Epithelioid Sarcoma | Alveolar Soft Part Sarcoma | Undifferentiated High Grade Pleomorphic... and other conditions

United States, Canada, Puerto Rico
European Organisation for Research and Treatment...
Pfizer

Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib (CREATE)

Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma | Locally Advanced and/or Metastatic Inflammatory Myofibroblastic Tumor | Locally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1 | Locally Advanced and/or Metastatic Alveolar Soft Part Sarcoma | Locally Advanced... and other conditions

France, Belgium, Netherlands, Germany, United Kingdom, Italy, Norway, Poland, Slovakia, Slovenia
University of Leipzig

Unknown

Tissue Characterization With Hyperspectral Imaging (HSI) (HSIT)

Inflammation | Inflammatory Bowel Diseases | Tumor | Tissue Perfusion

Germany

Medical specialists from France tagged as investigators in clinical trials studying Inflammatory Myofibroblastic Tumor

Clinical Trials on Inflammatory Myofibroblastic Tumor

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations